Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 24483943)

1.

ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.

Strömberg A, Fluur C, Miller J, Chung ML, Moser DK, Thylén I.

Pacing Clin Electrophysiol. 2014 Jul;37(7):834-42. doi: 10.1111/pace.12353. Epub 2014 Jan 31.

PMID:
24483943
2.

Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.

Kelley AS, Reid MC, Miller DH, Fins JJ, Lachs MS.

Am Heart J. 2009 Apr;157(4):702-8.e1. doi: 10.1016/j.ahj.2008.12.011. Epub 2009 Feb 23.

PMID:
19332199
3.

Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.

Thylén I, Wenemark M, Fluur C, Strömberg A, Bolse K, Årestedt K.

Eur J Cardiovasc Nurs. 2014 Apr;13(2):142-51. doi: 10.1177/1474515113515563. Epub 2013 Dec 1.

PMID:
24298191
4.

Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.

Russo JE.

Am J Nurs. 2011 Oct;111(10):26-35. doi: 10.1097/01.NAJ.0000406411.49438.91. Review.

PMID:
21926561
5.

[Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

Ladwig KH, Ischinger NF, Ronel J, Kolb C.

Herzschrittmacherther Elektrophysiol. 2011 Sep;22(3):151-6. doi: 10.1007/s00399-011-0138-x. Review. German.

PMID:
21769624
6.

Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?

Raphael CE, Koa-Wing M, Stain N, Wright I, Francis DP, Kanagaratnam P.

Pacing Clin Electrophysiol. 2011 Dec;34(12):1628-33. doi: 10.1111/j.1540-8159.2011.03223.x. Epub 2011 Sep 28.

PMID:
21955046
7.

Deactivation of implantable cardioverter-defibrillators: results of patient surveys.

Herman D, Stros P, Curila K, Kebza V, Osmancik P.

Europace. 2013 Jul;15(7):963-9. doi: 10.1093/europace/eus432. Epub 2013 Feb 27.

8.

Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.

Fluur C, Bolse K, Strömberg A, Thylén I.

Heart Lung. 2013 May-Jun;42(3):202-7. doi: 10.1016/j.hrtlng.2012.11.006. Epub 2012 Dec 27.

PMID:
23273655
9.

Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.

Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ.

Am J Cardiol. 2012 Jan 1;109(1):91-4. doi: 10.1016/j.amjcard.2011.08.011. Epub 2011 Sep 22.

PMID:
21943937
10.

Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.

Sherazi S, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, DiSalle MR, Haley JM, Shah AH.

Mayo Clin Proc. 2008 Oct;83(10):1139-41. doi: 10.4065/83.10.1139.

PMID:
18828973
11.

Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Kapa S, Mueller PS, Hayes DL, Asirvatham SJ.

Mayo Clin Proc. 2010 Nov;85(11):981-90. doi: 10.4065/mcp.2010.0431. Epub 2010 Sep 15.

12.

Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.

Niewald A, Broxterman J, Rosell T, Rigler S.

J Med Ethics. 2013 Feb;39(2):94-7. doi: 10.1136/medethics-2012-100613. Epub 2012 Nov 8.

PMID:
23139392
13.

Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.

Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH.

Am J Cardiol. 2011 Apr 1;107(7):1071-1075.e5. doi: 10.1016/j.amjcard.2010.11.036. Epub 2011 Feb 4.

14.

The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D.

Dtsch Arztebl Int. 2012 Aug;109(33-34):535-41. doi: 10.3238/arztebl.2012.0535. Epub 2012 Aug 20. Review.

15.

Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.

Pedersen SS, Chaitsing R, Szili-Torok T, Jordaens L, Theuns DA.

Am J Cardiol. 2013 May 15;111(10):1443-7. doi: 10.1016/j.amjcard.2013.01.296. Epub 2013 Mar 12.

PMID:
23490027
16.

The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.

Udlis KA.

J Cardiovasc Nurs. 2013 Nov-Dec;28(6):E65-73. doi: 10.1097/JCN.0b013e31827b9789.

PMID:
23348222
17.

Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.

Wright GA, Klein GJ, Gula LJ.

Curr Opin Cardiol. 2013 Jan;28(1):43-9. doi: 10.1097/HCO.0b013e32835b0b3b. Review.

PMID:
23128499
18.

Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.

Marinskis G, van Erven L; EHRA Scientific Initiatives Committee.

Europace. 2010 Aug;12(8):1176-7. doi: 10.1093/europace/euq272.

19.

Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Kramer DB, Kesselheim AS, Brock DW, Maisel WH.

Heart Rhythm. 2010 Nov;7(11):1537-42. doi: 10.1016/j.hrthm.2010.07.018. Epub 2010 Jul 19.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk